Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors

Status:
Completed

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

This is a study to assess the safety and tolerability of SNS-314 in advanced solid tumors in humans.

Phase 1

Sunesis Pharmaceuticals